PTEN and cancer: Here, PTEN knockout mice (Pten−/+) or knock-in mice expressing the loss-of-function and cancer-associated PTENG129E point mutation (PtenG129E/+) (17) were crossed to our Akt-FRET biosensor mice to map the activation status of AKT in these established long-term tumor models.